111 related articles for article (PubMed ID: 9781634)
1. Intracerebroventricular administration of leptin markedly enhances insulin sensitivity and systemic glucose utilization in conscious rats.
Shi ZQ; Nelson A; Whitcomb L; Wang J; Cohen AM
Metabolism; 1998 Oct; 47(10):1274-80. PubMed ID: 9781634
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of leptin in regulation of tissue glucose utilization in vivo.
Wang JL; Chinookoswong N; Scully S; Qi M; Shi ZQ
Endocrinology; 1999 May; 140(5):2117-24. PubMed ID: 10218962
[TBL] [Abstract][Full Text] [Related]
3. Chronic central leptin infusion enhances insulin-stimulated glucose metabolism and favors the expression of uncoupling proteins.
Cusin I; Zakrzewska KE; Boss O; Muzzin P; Giacobino JP; Ricquier D; Jeanrenaud B; Rohner-Jeanrenaud F
Diabetes; 1998 Jul; 47(7):1014-9. PubMed ID: 9648822
[TBL] [Abstract][Full Text] [Related]
4. Effects of leptin on insulin sensitivity in normal rats.
Sivitz WI; Walsh SA; Morgan DA; Thomas MJ; Haynes WG
Endocrinology; 1997 Aug; 138(8):3395-401. PubMed ID: 9231793
[TBL] [Abstract][Full Text] [Related]
5. Long-term effects of central leptin and resistin on body weight, insulin resistance, and beta-cell function and mass by the modulation of hypothalamic leptin and insulin signaling.
Park S; Hong SM; Sung SR; Jung HK
Endocrinology; 2008 Feb; 149(2):445-54. PubMed ID: 17991727
[TBL] [Abstract][Full Text] [Related]
6. Leptin restores euglycemia and normalizes glucose turnover in insulin-deficient diabetes in the rat.
Chinookoswong N; Wang JL; Shi ZQ
Diabetes; 1999 Jul; 48(7):1487-92. PubMed ID: 10389859
[TBL] [Abstract][Full Text] [Related]
7. Chronic leptin administration increases insulin-stimulated skeletal muscle glucose uptake and transport.
Yaspelkis BB; Ansari L; Ramey EL; Holland GJ; Loy SF
Metabolism; 1999 May; 48(5):671-6. PubMed ID: 10337873
[TBL] [Abstract][Full Text] [Related]
8. Anorectic effects of the cytokine, ciliary neurotropic factor, are mediated by hypothalamic neuropeptide Y: comparison with leptin.
Xu B; Dube MG; Kalra PS; Farmerie WG; Kaibara A; Moldawer LL; Martin D; Kalra SP
Endocrinology; 1998 Feb; 139(2):466-73. PubMed ID: 9449612
[TBL] [Abstract][Full Text] [Related]
9. Effects of intracerebroventricular leptin administration on food intake, body weight gain and diencephalic nitric oxide synthase activity in the mouse.
Calapai G; Corica F; Allegra A; Corsonello A; Sautebin L; De Gregorio T; Di Rosa M; Costantino G; Buemi M; Caputi AP
Br J Pharmacol; 1998 Oct; 125(4):798-802. PubMed ID: 9831917
[TBL] [Abstract][Full Text] [Related]
10. Effects of intravenously infused leptin on insulin sensitivity and on the expression of uncoupling proteins in brown adipose tissue.
Rouru J; Cusin I; Zakrzewska KE; Jeanrenaud B; Rohner-Jeanrenaud F
Endocrinology; 1999 Aug; 140(8):3688-92. PubMed ID: 10433228
[TBL] [Abstract][Full Text] [Related]
11. Metabolic responses to intracerebroventricular leptin and restricted feeding.
Wang T; Hartzell DL; Rose BS; Flatt WP; Hulsey MG; Menon NK; Makula RA; Baile CA
Physiol Behav; 1999 Jan 1-15; 65(4-5):839-48. PubMed ID: 10073490
[TBL] [Abstract][Full Text] [Related]
12. Intracerebroventricular leptin regulates hepatic but not peripheral glucose fluxes.
Liu L; Karkanias GB; Morales JC; Hawkins M; Barzilai N; Wang J; Rossetti L
J Biol Chem; 1998 Nov; 273(47):31160-7. PubMed ID: 9813020
[TBL] [Abstract][Full Text] [Related]
13. Central infusion of leptin improves insulin resistance and suppresses beta-cell function, but not beta-cell mass, primarily through the sympathetic nervous system in a type 2 diabetic rat model.
Park S; Ahn IS; Kim DS
Life Sci; 2010 Jun; 86(23-24):854-62. PubMed ID: 20388519
[TBL] [Abstract][Full Text] [Related]
14. Effects of central leptin infusion on the reward-potentiating effect of D-amphetamine.
Hao J; Cabeza de Vaca S; Pan Y; Carr KD
Brain Res; 2006 May; 1087(1):123-33. PubMed ID: 16600190
[TBL] [Abstract][Full Text] [Related]
15. Effects of central leptin administration on blood pressure in normotensive rats.
Casto RM; VanNess JM; Overton JM
Neurosci Lett; 1998 Apr; 246(1):29-32. PubMed ID: 9622200
[TBL] [Abstract][Full Text] [Related]
16. Rats with portal-caval vein transposition show hyperinsulinemia and insulin resistance.
Williamson MP; Behme MT; Dupré J; Grant DR; Guan J; Zhong R
Metabolism; 1996 Jan; 45(1):120-5. PubMed ID: 8544769
[TBL] [Abstract][Full Text] [Related]
17. Intracerebroventricular (i.c.v.) administration of mouse leptin in rats: behavioral specificity and effects on meal patterns.
Hulsey MG; Lu H; Wang T; Martin RJ; Baile CA
Physiol Behav; 1998 Dec; 65(3):445-55. PubMed ID: 9877410
[TBL] [Abstract][Full Text] [Related]
18. Effects of chronic central nervous system administration of agouti-related protein in pair-fed animals.
Small CJ; Kim MS; Stanley SA; Mitchell JR; Murphy K; Morgan DG; Ghatei MA; Bloom SR
Diabetes; 2001 Feb; 50(2):248-54. PubMed ID: 11272133
[TBL] [Abstract][Full Text] [Related]
19. Chronic central leptin infusion restores hyperglycemia independent of food intake and insulin level in streptozotocin-induced diabetic rats.
Hidaka S; Yoshimatsu H; Kondou S; Tsuruta Y; Oka K; Noguchi H; Okamoto K; Sakino H; Teshima Y; Okeda T; Sakata T
FASEB J; 2002 Apr; 16(6):509-18. PubMed ID: 11919153
[TBL] [Abstract][Full Text] [Related]
20. Long-term intracerebroventricular infusion of insulin, but not glucose, modulates body weight and hepatic insulin sensitivity by modifying the hypothalamic insulin signaling pathway in type 2 diabetic rats.
Park S; Hong SM; Ahn IS
Neuroendocrinology; 2009; 89(4):387-99. PubMed ID: 19176946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
